pyrazines has been researched along with imidazo(1,2-a)pyridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bénézech, V; Bompart, J; Bonnet, PA; Chapat, JP; Elliott, KR; Laurent, F; Michel, A; Pocock, TM; Portet, K; Small, RC; Subra, G; Vitse, O; Zanik, L | 1 |
| Baska, F; Boros, S; Dobos, J; Garamvölgyi, R; Illyés, E; Kékesi, L; Kéri, G; Őrfi, L; Sipos, A; Szabadkai, I; Szántai-Kis, C | 1 |
2 other study(ies) available for pyrazines and imidazo(1,2-a)pyridine
| Article | Year |
|---|---|
New imidazo(1,2-a)pyrazine derivatives with bronchodilatory and cyclic nucleotide phosphodiesterase inhibitory activities.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Bronchodilator Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Enzyme Inhibitors; Guinea Pigs; Imidazoles; Pyrazines; Pyridines; Structure-Activity Relationship; Trachea | 1999 |
Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Imidazoles; Melanoma; Molecular Structure; Pyrazines; Pyridines; Structure-Activity Relationship | 2016 |